AVALO THERAPEUTICS, INC. (AVTX) Capital expenditures 2016–2023
AVALO THERAPEUTICS, INC. (AVTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2023 · since FY2016: $34,883 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $95,000 | -15.9% |
| FY2021 | $113,000 | +79.4% |
| FY2020 | $63,000 | -76.0% |
| FY2019 | $262,013 | -53.6% |
| FY2018 | $564,415 | +2319.8% |
| FY2017 | $23,325 | -33.1% |
| FY2016 | $34,883 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice